ANAPLASTIC THYROID CANCER

Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC THYROID CANCER trials appear

Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 4 Completed 1 Terminated 1

New targeted drug shows promise for BRAF-Mutant cancers in early trial

Disease control Completed

This early-stage trial tested a new drug called CFT1946, alone or with other drugs, in 89 adults with solid tumors that have a BRAF V600 mutation, including melanoma, lung, colon, and thyroid cancers. The main goals were to check safety and find the best dose. The study is comple…

Matched conditions: ANAPLASTIC THYROID CANCER

Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC

ANAPLASTIC THYROID CANCER

Get alerted when new ANAPLASTIC THYROID CANCER trials appear

New targeted drug shows promise for BRAF-Mutant cancers in early trial